Cellmid 2017 Annual Report
52
NOTES TO THE
FINANCIAL STATEMENTS
CONTINUED
*Options were either exercised or lapsed during the financial year ended 30 June 2017.
The holders of ordinary shares are entitled to participate in dividends and the proceeds on winding up of the Company. On a
show of hands at meetings of the Company, each holder of ordinary shares has one vote in person or by proxy, and upon a poll
each share is entitled to one vote.
The Company does not have a limited amount of authorised capital and the fully paid ordinary shares have no par value.
18. ISSUED CAPITAL
2017 2016 2017 2016
Shares Shares $ $
Ordinary shares – fully paid 1,072,456,303 928,500,508 36,715,031 31,794,565
Unissued ordinary shares under option* 34,440,000 330,954,732 - 632,261
36,715,031 32,426,826
Consolidated
Issue Price 2017 2016 2017 2016
$ No. No. $ $
(a) Ordinary shares
At the beginning of the year 928,500,508 95,167,175 31,794,565 28,069,050
Shares issued – May 2017 0.027 2,074,074 - 56,000 -
Shares issued – March 2017 0.0306 1,000,000 - 30,600 -
Shares issued – March 2017 0.02 700,000 - 14,000 -
Shares issued – March 2017 0.034 250,000 - 8,500 -
Shares issued – March 2017 0.023 4,565,218 - 105,000 -
Shares issued – November 2016 0.03 35,483,334 - 1,064,500 -
Shares issued – November 2016 0.03 63,516,666 - 1,905,500 -
Shares issued – October 2016 0.034 32,394,541 - 1,101,401 -
Shares issued – October 2016 0.03 3,971,962 - 119,159 -
Shares issue costs, net of tax - - - (116,455) -
Listed options exercised/lapsed* - - 632,261 -
Shares issued – September 2015 0.03 - 23,333,333 - 700,000
Shares issued – August 2015 0.03 - 110,000,000 - 3,300,000
Shares issue costs, net of tax - - - (274,485)
At the end of the year 1,072,456,303 928,500,508 36,715,031 31,794,565